ALPHAHELIX MOL.DIAGN. SK1 (4MB) — Capital Reinvestment Ratio
ALPHAHELIX MOL.DIAGN. SK1 (4MB) has a Capital Reinvestment Ratio of 0.10x as of December 2022, meaning it reinvests 0% of its operating cash flow (€2.87 Million) in capital expenditures (€288.09K). Check tangible equity quality of ALPHAHELIX MOL.DIAGN. SK1 to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ALPHAHELIX MOL.DIAGN. SK1 Capital Reinvestment Ratio (2022–2022)
This chart tracks ALPHAHELIX MOL.DIAGN. SK1's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see ALPHAHELIX MOL.DIAGN. SK1 operating cash flow efficiency.
Annual Capital Reinvestment Ratio for ALPHAHELIX MOL.DIAGN. SK1 (2022–2022)
Year-by-year Capital Reinvestment Ratio for ALPHAHELIX MOL.DIAGN. SK1 from 2022 to 2022. See ALPHAHELIX MOL.DIAGN. SK1 free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.10x | €2.87 Million | €288.09K | — |